PSTX Financial Facts
Research and development: 168.56KRevenues: 5.21M
See Full Income Statement
Total current assets: 10.59M
Accumulated deficit: -63.66M
See Full Balance Sheet
Poseida Therapeutics, Inc. (PSTX) Earnings
|
Expand Research on PSTX
| Next EPS Date | N/A | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +65.2% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | +8.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/25  |
Q424 | N/A | -$0.33 | N/A | N/A | $16.25M | N/A | N/A | N/A | ||
| 11/7/24 | Q324 | $0.21 | -$0.42 | +$0.63 | $71.75M | $16.25M | N/A |  | | Details | |
| 8/8/24 | Q224 | N/A | -$0.41 | N/A | N/A | $15.42M | N/A | N/A | N/A | ||
| 5/14/24 | Q124 | -$0.25 | -$0.42 | +$0.17 | $28.14M | $10.03M | N/A | | | Details | |
| 5/7/24 | Q124 | N/A | -$0.42 | N/A | N/A | $10.03M | N/A | N/A | N/A | ||
| 3/7/24 | Q423 | -$0.27 | -$0.39 | +$0.12 | $24.99M | $6.65M | N/A | | | Details | |
| 11/8/23 | Q323 | N/A | -$0.29 | N/A | N/A | $18.87M | N/A | N/A | N/A | ||
| 8/10/23 | Q223 | N/A | -$0.53 | N/A | N/A | $11.96M | N/A | N/A | N/A |
